Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
Harrow (Nasdaq: HROW), a North American eyecare pharmaceutical company, has scheduled its third quarter 2024 financial results announcement for November 13, 2024, after market close. The company will publish its quarterly Letter to Stockholders on its website and host a conference call with a business update on November 14, 2024, at 8:00 a.m. Eastern Time. Interested participants can join via webcast through Harrow's website or by telephone after registering in advance.
Harrow (Nasdaq: HROW), un'azienda farmaceutica nordamericana specializzata nell'eyecare, ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 per il 13 novembre 2024, dopo la chiusura del mercato. L'azienda pubblicherà la sua lettera trimestrale agli azionisti sul proprio sito web e ospiterà una conferenza telefonica con un aggiornamento aziendale il 14 novembre 2024, alle 8:00 ora orientale. I partecipanti interessati possono unirsi tramite webcast attraverso il sito di Harrow o per telefono dopo aver effettuato la registrazione in anticipo.
Harrow (Nasdaq: HROW), una empresa farmacéutica de cuidado ocular de América del Norte, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el 13 de noviembre de 2024, después del cierre del mercado. La compañía publicará su carta trimestral a los accionistas en su sitio web y organizará una llamada de conferencia con una actualización empresarial el 14 de noviembre de 2024, a las 8:00 a.m. hora del Este. Los participantes interesados pueden unirse a través de una transmisión web en el sitio de Harrow o por teléfono tras registrarse de antemano.
해로우 (Nasdaq: HROW)는 북미의 안과 관련 제약회사로, 2024년 3분기 재무 결과 발표를 2024년 11월 13일 시장 종료 후로 예정하고 있습니다. 회사는 분기별 주주 서한을 웹사이트에 게시하고 2024년 11월 14일 오전 8:00(동부 표준시)에 사업 업데이트를 포함한 컨퍼런스 콜을 개최할 예정입니다. 관심 있는 참가자들은 해로우 웹사이트를 통해 웹캐스트에 참여하거나 사전 등록 후 전화로 참여할 수 있습니다.
Harrow (Nasdaq: HROW), une entreprise pharmaceutique nord-américaine spécialisée dans le soin des yeux, a prévu d'annoncer ses résultats financiers du troisième trimestre 2024 pour le 13 novembre 2024, après la fermeture du marché. La société publiera sa lettre trimestrielle aux actionnaires sur son site internet et organisera une conférence téléphonique avec une mise à jour sur l'activité le 14 novembre 2024 à 8h00, heure de l'Est. Les participants intéressés peuvent se joindre via un webinaire sur le site de Harrow ou par téléphone après s'être inscrits à l'avance.
Harrow (Nasdaq: HROW), ein nordamerikanisches Pharmaunternehmen im Bereich Augenpflege, hat die Bekanntgabe seiner finanziellen Ergebnisse für das dritte Quartal 2024 für den 13. November 2024 nach Marktschluss festgelegt. Das Unternehmen wird seinen vierteljährlichen Brief an die Aktionäre auf seiner Website veröffentlichen und am 14. November 2024 um 8:00 Uhr Eastern Time eine Telefonkonferenz mit einem Unternehmensupdate abhalten. Interessierte Teilnehmer können über einen Webcast auf der Website von Harrow oder telefonisch nach vorheriger Registrierung teilnehmen.
- None.
- None.
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on November 14, 2024
Conference Call Information
Participants can access the live conference call via webcast on the “Investors” page of Harrow’s website. To participate via telephone, please register in advance using this link. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call. A replay of the conference call and webcast will be archived on the Company’s website for one year.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031905317/en/
Jamie Webb
Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737
Source: Harrow, Inc.
FAQ
When will Harrow (HROW) release Q3 2024 earnings?
When is Harrow's (HROW) Q3 2024 earnings call?
How can I access Harrow's (HROW) Q3 2024 earnings call?
Where can I find Harrow's (HROW) Q3 2024 Letter to Stockholders?
